Review



e coli o157 h7 2257  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    ATCC e coli o157 h7 2257
    <t> E. coli </t> O175:H7 strains used for antibacterial experiments.
    E Coli O157 H7 2257, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 117 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/e+coli+o157+h7+2257/HL-60%2FMX2/pmc09103322-79-37-54
    Average 93 stars, based on 117 article reviews
    e coli o157 h7 2257 - by Bioz Stars, 2026-09
    93/100 stars

    Images

    1) Product Images from "Probiotic-Mediated Biosynthesis of Silver Nanoparticles and Their Antibacterial Applications against Pathogenic Strains of Escherichia coli O157:H7"

    Article Title: Probiotic-Mediated Biosynthesis of Silver Nanoparticles and Their Antibacterial Applications against Pathogenic Strains of Escherichia coli O157:H7

    Journal: Polymers

    doi: 10.3390/polym14091834

    E. coli O175:H7 strains used for antibacterial experiments.
    Figure Legend Snippet: E. coli O175:H7 strains used for antibacterial experiments.

    Techniques Used: Isolation

    Antibacterial activity of synthesized AgNPs at 1000 μg/mL concentrations in the water against E. coli O157:H7 strains ( A – I ).
    Figure Legend Snippet: Antibacterial activity of synthesized AgNPs at 1000 μg/mL concentrations in the water against E. coli O157:H7 strains ( A – I ).

    Techniques Used: Activity Assay, Synthesized

    Antibacterial efficacy of probiotic-mediated synthesized AgNPs against E. coli O157:H7 strains.
    Figure Legend Snippet: Antibacterial efficacy of probiotic-mediated synthesized AgNPs against E. coli O157:H7 strains.

    Techniques Used: Synthesized, Inhibition

    Antibacterial activity of some commercial antibiotics against nine E. coli O157:H7 strains ( A – I ). Abbreviations: P (penicillin G, 10 μg/disc), E (erythromycin, 15 μg/disc), and VA (vancomycin, 30 μg/disc).
    Figure Legend Snippet: Antibacterial activity of some commercial antibiotics against nine E. coli O157:H7 strains ( A – I ). Abbreviations: P (penicillin G, 10 μg/disc), E (erythromycin, 15 μg/disc), and VA (vancomycin, 30 μg/disc).

    Techniques Used: Activity Assay

    Antibacterial efficacy of some commercial antibiotics against E. coli O157:H7 strains—no inhibition zone.
    Figure Legend Snippet: Antibacterial efficacy of some commercial antibiotics against E. coli O157:H7 strains—no inhibition zone.

    Techniques Used: Inhibition

    Growth curves of nine E. coli O157:H7 strains ( A – I ) cultured in LB broth with various concentrations of synthesized AgNPs to determine MIC. Control (●); 200 μg/mL (◦); 100 μg/mL (▼) 50 μg/mL (△); 25 μg/mL (§); 12.5 μg/mL (□); 6.25 μg/mL (w); 3.12 μg/mL (◊).
    Figure Legend Snippet: Growth curves of nine E. coli O157:H7 strains ( A – I ) cultured in LB broth with various concentrations of synthesized AgNPs to determine MIC. Control (●); 200 μg/mL (◦); 100 μg/mL (▼) 50 μg/mL (△); 25 μg/mL (§); 12.5 μg/mL (□); 6.25 μg/mL (w); 3.12 μg/mL (◊).

    Techniques Used: Cell Culture, Synthesized, Control

    MBC of probiotic-mediated synthesized AgNPs against E. coli O157:H7 strains ( A – I ).
    Figure Legend Snippet: MBC of probiotic-mediated synthesized AgNPs against E. coli O157:H7 strains ( A – I ).

    Techniques Used: Synthesized

    FE-SEM images of normal E. coli O157:H7 (ATCC 35150) ( A , B ) and 1 × MBC probiotic-mediated synthesized AgNPs treated E. coli O157:H7 (ATCC 35150) ( C , D ).
    Figure Legend Snippet: FE-SEM images of normal E. coli O157:H7 (ATCC 35150) ( A , B ) and 1 × MBC probiotic-mediated synthesized AgNPs treated E. coli O157:H7 (ATCC 35150) ( C , D ).

    Techniques Used: Synthesized

    Related Articles

    Synthesized:

    Article Title: Probiotic-Mediated Biosynthesis of Silver Nanoparticles and Their Antibacterial Applications against Pathogenic Strains of Escherichia coli O157:H7
    Article Snippet: .. The MBC of synthesized AgNPs was 25 μg/mL for E. coli O157:H7 ATCC 43895, E. coli O157:H7 ATCC 35150, E. coli O157:H7 ATCC 43889, E. coli O157:H7 ATCC 43,890, and E. coli ATCC 25,922, and 50 μg/mL for E. coli O157:H7 2257, E. coli O157: NM 3204-92, E. coli O157:H7 8624 and E. coli O157:H7 ATCC 43,894 ( A–I). .. The structural and morphological alterations of E. coli O157:H7 ATCC 35,150 cells treated with probiotic-mediated synthesized AgNPs were directly observed using FE-SEM ( ).



    Similar Products

    e coli o157 h7 2257  (ATCC)
    93
    ATCC e coli o157 h7 2257
    <t> E. coli </t> O175:H7 strains used for antibacterial experiments.
    E Coli O157 H7 2257, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/e+coli+o157+h7+2257/HL-60%2FMX2/pmc09103322-79-37-54
    Average 93 stars, based on 1 article reviews
    e coli o157 h7 2257 - by Bioz Stars, 2026-09
    93/100 stars
    		  Buy from Supplier

    Image Search Results


    E. coli O175:H7 strains used for antibacterial experiments.

    Journal: Polymers

    Article Title: Probiotic-Mediated Biosynthesis of Silver Nanoparticles and Their Antibacterial Applications against Pathogenic Strains of Escherichia coli O157:H7

    doi: 10.3390/polym14091834

    Figure Lengend Snippet: E. coli O175:H7 strains used for antibacterial experiments.

    Article Snippet: Minimum bactericidal concentrations (MBCs) were 25 μg/mL for E. coli O157:H7 ATCC 35150, E. coli O157:H7 ATCC 43895, E. coli O157:H7 ATCC 43890, E. coli O157:H7 ATCC 43889, and E. coli ATCC 25922; and 50 μg/mL for E. coli O157:H7 2257, E. coli O157: NM 3204-92, E. coli O157:H7 8624 and E. coli O157:H7 ATCC 43894.

    Techniques: Isolation

    Antibacterial activity of synthesized AgNPs at 1000 μg/mL concentrations in the water against E. coli O157:H7 strains ( A – I ).

    Journal: Polymers

    Article Title: Probiotic-Mediated Biosynthesis of Silver Nanoparticles and Their Antibacterial Applications against Pathogenic Strains of Escherichia coli O157:H7

    doi: 10.3390/polym14091834

    Figure Lengend Snippet: Antibacterial activity of synthesized AgNPs at 1000 μg/mL concentrations in the water against E. coli O157:H7 strains ( A – I ).

    Article Snippet: Minimum bactericidal concentrations (MBCs) were 25 μg/mL for E. coli O157:H7 ATCC 35150, E. coli O157:H7 ATCC 43895, E. coli O157:H7 ATCC 43890, E. coli O157:H7 ATCC 43889, and E. coli ATCC 25922; and 50 μg/mL for E. coli O157:H7 2257, E. coli O157: NM 3204-92, E. coli O157:H7 8624 and E. coli O157:H7 ATCC 43894.

    Techniques: Activity Assay, Synthesized

    Antibacterial efficacy of probiotic-mediated synthesized AgNPs against E. coli O157:H7 strains.

    Journal: Polymers

    Article Title: Probiotic-Mediated Biosynthesis of Silver Nanoparticles and Their Antibacterial Applications against Pathogenic Strains of Escherichia coli O157:H7

    doi: 10.3390/polym14091834

    Figure Lengend Snippet: Antibacterial efficacy of probiotic-mediated synthesized AgNPs against E. coli O157:H7 strains.

    Article Snippet: Minimum bactericidal concentrations (MBCs) were 25 μg/mL for E. coli O157:H7 ATCC 35150, E. coli O157:H7 ATCC 43895, E. coli O157:H7 ATCC 43890, E. coli O157:H7 ATCC 43889, and E. coli ATCC 25922; and 50 μg/mL for E. coli O157:H7 2257, E. coli O157: NM 3204-92, E. coli O157:H7 8624 and E. coli O157:H7 ATCC 43894.

    Techniques: Synthesized, Inhibition

    Antibacterial activity of some commercial antibiotics against nine E. coli O157:H7 strains ( A – I ). Abbreviations: P (penicillin G, 10 μg/disc), E (erythromycin, 15 μg/disc), and VA (vancomycin, 30 μg/disc).

    Journal: Polymers

    Article Title: Probiotic-Mediated Biosynthesis of Silver Nanoparticles and Their Antibacterial Applications against Pathogenic Strains of Escherichia coli O157:H7

    doi: 10.3390/polym14091834

    Figure Lengend Snippet: Antibacterial activity of some commercial antibiotics against nine E. coli O157:H7 strains ( A – I ). Abbreviations: P (penicillin G, 10 μg/disc), E (erythromycin, 15 μg/disc), and VA (vancomycin, 30 μg/disc).

    Article Snippet: Minimum bactericidal concentrations (MBCs) were 25 μg/mL for E. coli O157:H7 ATCC 35150, E. coli O157:H7 ATCC 43895, E. coli O157:H7 ATCC 43890, E. coli O157:H7 ATCC 43889, and E. coli ATCC 25922; and 50 μg/mL for E. coli O157:H7 2257, E. coli O157: NM 3204-92, E. coli O157:H7 8624 and E. coli O157:H7 ATCC 43894.

    Techniques: Activity Assay

    Antibacterial efficacy of some commercial antibiotics against E. coli O157:H7 strains—no inhibition zone.

    Journal: Polymers

    Article Title: Probiotic-Mediated Biosynthesis of Silver Nanoparticles and Their Antibacterial Applications against Pathogenic Strains of Escherichia coli O157:H7

    doi: 10.3390/polym14091834

    Figure Lengend Snippet: Antibacterial efficacy of some commercial antibiotics against E. coli O157:H7 strains—no inhibition zone.

    Article Snippet: Minimum bactericidal concentrations (MBCs) were 25 μg/mL for E. coli O157:H7 ATCC 35150, E. coli O157:H7 ATCC 43895, E. coli O157:H7 ATCC 43890, E. coli O157:H7 ATCC 43889, and E. coli ATCC 25922; and 50 μg/mL for E. coli O157:H7 2257, E. coli O157: NM 3204-92, E. coli O157:H7 8624 and E. coli O157:H7 ATCC 43894.

    Techniques: Inhibition

    Growth curves of nine E. coli O157:H7 strains ( A – I ) cultured in LB broth with various concentrations of synthesized AgNPs to determine MIC. Control (●); 200 μg/mL (◦); 100 μg/mL (▼) 50 μg/mL (△); 25 μg/mL (§); 12.5 μg/mL (□); 6.25 μg/mL (w); 3.12 μg/mL (◊).

    Journal: Polymers

    Article Title: Probiotic-Mediated Biosynthesis of Silver Nanoparticles and Their Antibacterial Applications against Pathogenic Strains of Escherichia coli O157:H7

    doi: 10.3390/polym14091834

    Figure Lengend Snippet: Growth curves of nine E. coli O157:H7 strains ( A – I ) cultured in LB broth with various concentrations of synthesized AgNPs to determine MIC. Control (●); 200 μg/mL (◦); 100 μg/mL (▼) 50 μg/mL (△); 25 μg/mL (§); 12.5 μg/mL (□); 6.25 μg/mL (w); 3.12 μg/mL (◊).

    Article Snippet: Minimum bactericidal concentrations (MBCs) were 25 μg/mL for E. coli O157:H7 ATCC 35150, E. coli O157:H7 ATCC 43895, E. coli O157:H7 ATCC 43890, E. coli O157:H7 ATCC 43889, and E. coli ATCC 25922; and 50 μg/mL for E. coli O157:H7 2257, E. coli O157: NM 3204-92, E. coli O157:H7 8624 and E. coli O157:H7 ATCC 43894.

    Techniques: Cell Culture, Synthesized, Control

    MBC of probiotic-mediated synthesized AgNPs against E. coli O157:H7 strains ( A – I ).

    Journal: Polymers

    Article Title: Probiotic-Mediated Biosynthesis of Silver Nanoparticles and Their Antibacterial Applications against Pathogenic Strains of Escherichia coli O157:H7

    doi: 10.3390/polym14091834

    Figure Lengend Snippet: MBC of probiotic-mediated synthesized AgNPs against E. coli O157:H7 strains ( A – I ).

    Article Snippet: Minimum bactericidal concentrations (MBCs) were 25 μg/mL for E. coli O157:H7 ATCC 35150, E. coli O157:H7 ATCC 43895, E. coli O157:H7 ATCC 43890, E. coli O157:H7 ATCC 43889, and E. coli ATCC 25922; and 50 μg/mL for E. coli O157:H7 2257, E. coli O157: NM 3204-92, E. coli O157:H7 8624 and E. coli O157:H7 ATCC 43894.

    Techniques: Synthesized

    FE-SEM images of normal E. coli O157:H7 (ATCC 35150) ( A , B ) and 1 × MBC probiotic-mediated synthesized AgNPs treated E. coli O157:H7 (ATCC 35150) ( C , D ).

    Journal: Polymers

    Article Title: Probiotic-Mediated Biosynthesis of Silver Nanoparticles and Their Antibacterial Applications against Pathogenic Strains of Escherichia coli O157:H7

    doi: 10.3390/polym14091834

    Figure Lengend Snippet: FE-SEM images of normal E. coli O157:H7 (ATCC 35150) ( A , B ) and 1 × MBC probiotic-mediated synthesized AgNPs treated E. coli O157:H7 (ATCC 35150) ( C , D ).

    Article Snippet: Minimum bactericidal concentrations (MBCs) were 25 μg/mL for E. coli O157:H7 ATCC 35150, E. coli O157:H7 ATCC 43895, E. coli O157:H7 ATCC 43890, E. coli O157:H7 ATCC 43889, and E. coli ATCC 25922; and 50 μg/mL for E. coli O157:H7 2257, E. coli O157: NM 3204-92, E. coli O157:H7 8624 and E. coli O157:H7 ATCC 43894.

    Techniques: Synthesized